Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
ViroMissile, Inc.
AstraZeneca
Genentech, Inc.
USWM, LLC (dba US WorldMeds)
xCures
Daiichi Sankyo
Second Life Therapeutics
Novartis
NeoTX Therapeutics Ltd.
Tempus AI
Massive Bio, Inc.
Actym Therapeutics, Inc.
Travera Inc
Pfizer
Arcus Biosciences, Inc.
Guardant Health, Inc.
Paradigm Health
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Tempus AI
Revolution Medicines, Inc.
Labcorp Corporation of America Holdings, Inc
Aminex Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
ADC Therapeutics S.A.
Pliant Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
Adaptimmune
Fate Therapeutics
Kineta Inc.
Prelude Therapeutics
Quadriga Biosciences, Inc.
Incyte Corporation
Revolution Medicines, Inc.
Incyte Corporation
Incyte Corporation
SpeciCare
Incyte Corporation
MultiVir, Inc.
Shenzhen BinDeBio Ltd.
Santa Maria Biotherapeutics
Celldex Therapeutics
ImmunoFrontier, Inc.
INSYS Therapeutics Inc
Delcath Systems Inc.